Insecticides (India) is currently trading at Rs. 674.00, up by 27.50 points or 4.25% from its previous closing of Rs. 646.50 on the BSE.
The scrip opened at Rs. 662.55 and has touched a high and low of Rs. 674.00 and Rs. 648.05 respectively. So far 1559 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 1084.65 on 28-Aug-2024 and a 52 week low of Rs. 460.50 on 19-Mar-2024.
Last one week high and low of the scrip stood at Rs. 695.80 and Rs. 640.20 respectively. The current market cap of the company is Rs. 1957.70 crore.
The promoters holding in the company stood at 72.16%, while Institutions and Non-Institutions held 14.49% and 13.36% respectively.
Insecticides (India) has launched, a new revolutionary Insecticide, Centran. This will be a pioneering solution for tackling stem borers in paddy. With its dual-action formula, Centran effectively controls stem bores and help the farmers to achieve healthier crops and better productivity.
Paddy is the backbone of the Indian farmers. Stem borers pose a significant threat to their hard work. To address this, new age insecticide Centran has been developed by the R&D Team of Insecticides (India). Centran is a unique blend of dual active ingredients for pest control and crop nourishment. The product supports robust root development, improves tiller growth, and delivers superior yields, ensuring a higher return on investment for growers.
With a strong distribution network and a legacy of empowering agriculture, the company continues to bring impactful innovations that resonate with the needs of those who grow the nation’s food.
Insecticides (India) is engaged in the manufacturing activities of agro chemicals, pesticides and technical products for agriculture purposes.
| Company Name | CMP |
|---|---|
| UPL | 665.00 |
| PI Industries | 3144.45 |
| Bayer CropScience | 4900.45 |
| Sharda Cropchem | 1109.70 |
| Sumitomo Chemical | 441.95 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: